Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

argenx SE

ARGX•NASDAQ
Healthcare
Biotechnology
$847.26
$2.85(0.34%)
U.S. Market opens in 12h 52m

ARGX News Today: Stay Updated with the Latest argenx SE News in Real Time

Find ARGX news now at Meyka AI. Stay informed with the latest argenx SE stocks updates, including price news, market analysis, and expert insights.

Argenx Releases H1 2025 Financials and Q2 Business Highlights
📅 7 months ago

Argenx Releases H1 2025 Financials and Q2 Business Highlights

Argenx, a global immunology company dedicated to improving the lives of people suffering from severe autoimmune diseases, has published its first-half 2025 financial results and second-quarter business highlights. The company’s robust pipeline development and strategic partnerships continue to shape its position as a biotech leader in rare diseases. Strong Revenue Growth Driven by Vyvgart Franchise…

Read more

ARGX News FAQ